Torii Pharmaceutical Co., Ltd. (4551.T)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap97.10B
EV97.10B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Revenue
324.4
465.1
448.9
478.2
466.4
320.6
310.9
350.4
364.6
370.9
Revenue % Chg.
-16.8%
43.4%
-3.5%
6.5%
-2.5%
-31.3%
-3.0%
12.7%
4.1%
3.5%
Cost of Revenue
153.5
229.8
225.8
233.3
237.4
154.4
148.8
168.9
190.3
194.8
Gross Profit
170.9
235.4
223.1
244.9
229.0
166.2
162.1
181.5
174.3
176.1
Gross Profit Margin
52.7%
50.6%
49.7%
51.2%
49.1%
51.9%
52.1%
51.8%
47.8%
47.5%
R&D Expenses
25.4
39.0
34.7
34.4
30.9
22.0
4.4
6.2
12.4
26.4
Selling, General, & Admin Expenses
27.0
38.4
37.3
38.0
38.6
21.1
24.7
31.2
11.8
12.3
Other Expenses
88.4
121.2
122.6
125.7
122.6
112.4
97.6
109.3
108.8
108.9
Operating Income
30.1
36.7
28.5
46.8
36.9
10.7
35.3
34.7
41.3
28.4
Operating Income Margin
9.3%
7.9%
6.3%
9.8%
7.9%
3.3%
11.4%
9.9%
11.3%
7.7%
Total Other Income/Expenses Net
-1.9
2.5
1.8
0.7
-14.3
270.4
-3.8
0.8
1.4
1.9
Income Before Tax
28.2
39.2
30.2
47.5
22.6
281.1
31.5
35.5
42.7
30.4
Income Before Tax Margin
8.7%
8.4%
6.7%
9.9%
4.8%
87.7%
10.1%
10.1%
11.7%
8.2%
Income Tax Expense
10.1
12.9
9.1
12.3
13.9
77.0
5.4
10.4
13.3
9.7
Net Income
18.0
26.3
21.2
35.2
8.7
204.1
26.1
25.2
29.4
20.7
Net Income Margin
5.6%
5.7%
4.7%
7.4%
1.9%
63.6%
8.4%
7.2%
8.1%
5.6%
Weighted Avg. Shares Out
28.3
28.3
28.3
28.0
28.1
28.1
28.1
28.1
28.1
66.6
EPS
0.6
0.9
0.7
1.3
0.3
7.3
0.9
0.9
1.0
0.4
EPS % Chg.
30.8%
45.8%
-19.4%
67.5%
-75.3%
2248.8%
-87.2%
-3.5%
16.9%
-55.7%
Weighted Avg. Shares Out Dil
28.3
28.3
28.3
28.0
28.1
28.1
28.1
28.1
28.1
67.8
EPS Diluted
0.6
0.9
0.7
1.3
0.3
7.3
0.9
0.9
1.0
0.3
Interest Income
0.4
0.6
0.3
0.2
0.4
1.0
1.0
1.1
1.2
1.4
Interest Expense
2.7
-0.9
-0.4
0.0
15.3
-268.5
5.9
1.1
-0.9
-0.8
EBIT
25.9
40.7
31.0
47.7
7.7
550.6
26.6
35.5
44.8
32.5
EBIT Margin
8.0%
8.8%
6.9%
10.0%
1.7%
171.7%
8.6%
10.1%
12.3%
8.8%
Depreciation & Amortization
7.7
12.5
11.3
9.7
8.7
9.3
6.4
4.9
3.8
1.0
EBITDA
33.7
53.2
42.3
57.4
16.4
559.9
33.0
40.5
48.7
33.6
EBITDA Margin
10.4%
11.4%
9.4%
12.0%
3.5%
174.6%
10.6%
11.6%
13.3%
9.1%